Clancy Sees Future For Long-Term Comparative Effectiveness Research
This article was originally published in The Gray Sheet
Executive Summary
A leading government proponent of evidence-based medicine is looking beyond stimulus funding that allocates hundreds of millions of dollars to comparative effectiveness research and is working to keep it viable for the long term